Nivalis Therapeutics Inc (NVLS.OQ)

NVLS.OQ on NASDAQ Stock Exchange Global Market

4.86USD
5 Feb 2016
Change (% chg)

-- (--)
Prev Close
$4.86
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
24,377
52-wk High
$20.23
52-wk Low
$4.41

NVLS.OQ

Chart for NVLS.OQ

About

Nivalis Therapeutics, Inc. is a United States-based clinical-stage pharmaceutical company. It is engaged in the discovery, development and commercialization of product candidates for patients with cystic fibrosis. The Company has developed a portfolio of small molecule inhibitors of S-nitrosoglutathione reductase (GSNOR), which... (more)

Overall

Beta: --
Market Cap(Mil.): $75.10
Shares Outstanding(Mil.): 15.45
Dividend: --
Yield (%): --

Financials

  NVLS.OQ Industry Sector
P/E (TTM): -- 36.97 38.72
EPS (TTM): -1.35 -- --
ROI: -44.32 6.90 14.47
ROE: -51.21 8.97 15.40
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : ValuEngine, Inc.
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Ford Investor Services, Inc.
$12.00
Provider : GlobalData
$300.00
Provider : ValuEngine, Inc.
$49.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks